Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against
The Lash Group


CTI to seek recovery from The Lash Group for damages including reimbursement
of prior expenses from the 2007 settlement with United States government
concerning TRISENOX





SEATTLE, Nov. 20 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI)
(Nasdaq and MTA: CTIC) announced today that the Ninth Circuit Court of
Appeals reversed a U.S. District Court order and ruled that CTI should be
allowed to pursue all of its claims against The Lash Group, sending the case
back to the District Court for trial. CTI filed a complaint against The Lash
Group, CTI's former third-party reimbursement consultant for CTI's product
TRISENOX, in 2007 seeking $22.8 million in damages for expenses already
incurred related to the investigation, defense and a settlement of claims by
the U.S. government concerning Medicare reimbursement for TRISENOX and other
business losses.


In 2007, CTI settled the claims by the U.S. government without admitting
liability and filed a lawsuit including claims that The Lash Group had
breached its contractual obligations to CTI as related to its services, as
well as an obligation to indemnify the company for damages related to the
settlement. CTI sold TRISENOX in 2005 to Cephalon, Inc.

ti dirò di più: vatti a vedere il grafico di medio lungo e dimmi se gli
oscillatori (dmi, rsi, stocazzi e vari...) non stanno messi come stavano
verso febbraio - marzo, prima del d-day

adesso vado di corsa, ma entro lunedi conto di postare un grafico poi ne
parliamo, magari anche con lo sciacallo...



--
_______________________________________________
"Abbi il coraggio di servirti della tua propria ragione" (I. Kant)
"magomerlino" <okispamthassos@iol.it> ha scritto nel messaggio
news:EGHNm.96717$1s6.6347@twister2.libero.it...
> Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim
> Against The Lash Group
> CTI to seek recovery from The Lash Group for damages including
> reimbursement of prior expenses from the 2007 settlement with United
> States government concerning TRISENOX
> SEATTLE, Nov. 20 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI)
> (Nasdaq and MTA: CTIC) announced today that the Ninth Circuit Court of
> Appeals reversed a U.S. District Court order and ruled that CTI should be
> allowed to pursue all of its claims against The Lash Group, sending the
> case back to the District Court for trial. CTI filed a complaint against
> The Lash Group, CTI's former third-party reimbursement consultant for
> CTI's product TRISENOX, in 2007 seeking $22.8 million in damages for
> expenses already incurred related to the investigation, defense and a
> settlement of claims by the U.S. government concerning Medicare
> reimbursement for TRISENOX and other business losses.
> In 2007, CTI settled the claims by the U.S. government without admitting
> liability and filed a lawsuit including claims that The Lash Group had
> breached its contractual obligations to CTI as related to its services, as
> well as an obligation to indemnify the company for damages related to the
> settlement. CTI sold TRISENOX in 2005 to Cephalon, Inc.

CELL THERAPEUTICS VINCE L'APPELLO FEDERALE E VIENE

AUTORIZZATA A PERSEGUIRE LA PROPRIA

RIVENDICAZIONE DI USD 22,8 MILIONI CONTRO THE LASH

GROUP

i soldi non ci sono ancra

"mascheroni" <go@west> ha scritto nel messaggio
news:4b07d7c1$0$8857$4fafbaef@reader5.news.tin.it. ..
> CELL THERAPEUTICS VINCE L'APPELLO FEDERALE E VIENE
> AUTORIZZATA A PERSEGUIRE LA PROPRIA
> RIVENDICAZIONE DI USD 22,8 MILIONI CONTRO THE LASH
> GROUP
> i soldi non ci sono ancra



negli usa se non cacci i soldi ti fanno fare una brutta fine,specialmente se
li tieni in cassa,mica come qua che se uno non vuol pagare ,campa
cavallo....